Guoyuan International issued a research report on Essex Bio-Technology on 1 April 2026. Essex posted steady operating performance growth in…
Browsing: Essex Bio -Technology Limited
– Multiple Regulatory Approvals and Strategic Collaborations Strengthened Market Position Key Results Highlights: – Revenue Growth: 8.6% increase to approximately HK$1,813.8…
Essex Bio-Technology Limited (EssexBio or the Company; HKG: 1061) today announces its successful participation in the 41st Asia-Pacific Academy of…
Essex Bio-Technology Limited (Essex or the Group, HKG: 1061) is pleased to announce that a Biologics License Application (BLA) for…
Essex Bio-Technology Ltd. (Essex or the Group, HKG: 1061) is pleased to announce that its wholly-owned subsidiary, Majeton Pte. Ltd.…
Essex Bio-Technology Ltd. (Essex or the Group, HKG: 1061) is pleased to announce that its wholly-owned subsidiary, Essex Medipharma (Zhuhai)…
Essex Bio-Technology Limited (the Company, together with its subsidiaries, the Group) wishes to announce that Essex Bio-Investment Limited (Essex Bio-Investment),…
Essex Bio-Technology Ltd (EssexBio or the Group, Stock Code: HKG:1061) is pleased and honoured to announce that it is included…